UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 253

Sortiert nach

Liver transplantation--an update

Deutsche medizinische Wochenschrift (1946), 2013-07, Vol.138 (28-29), p.1471

2013

Link zum Volltext

Verfügbarkeit prüfen

Donor Specific Antibodies Post Liver Transplant: Predictors and Protectors

Journal of hepatology, 2016, Vol.64 (2), p.S544-S544

2016

Link zum Volltext

Verfügbarkeit prüfen

Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo

Transplantation proceedings, 2017-10, Vol.49 (8), p.1947-1955

2017

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis viruses: live and let die

Liver international, 2007-04, Vol.27 (3), p.293-301

2007

Link zum Volltext

Verfügbarkeit prüfen

P0693 : The tumor suppressor PML mediates everolimus- induced changes of the HCV replication activity

Journal of hepatology, 2015-04, Vol.62, p.S582-S582

2015

Link zum Volltext

Verfügbarkeit prüfen

Daclatasvir plus Sofosbuvir with or without Ribavirin for Treatment of Chronic HCV Infection in Patients with Advanced Liver Disease: Results of a European Compassionate use Program

JOURNAL OF HEPATOLOGY, 2016, Vol.64 (2), p.S825-S825

2016

Link zum Volltext

Verfügbarkeit prüfen

Daclatasvir plus Sofosbuvir with or without Ribavirin for the Treatment of Chronic HCV Infection in Patients with Decompensated Cirrhosis: Results of a European Multicentre Compassionate Use Program

JOURNAL OF HEPATOLOGY, 2016, Vol.64 (2), p.S781-S782

2016

Link zum Volltext

Verfügbarkeit prüfen

How do anaesthetists in New Zealand disseminate critical airway information?

Anaesthesia and intensive care, 2013-05, Vol.41 (3), p.334-341

2013

Link zum Volltext

Verfügbarkeit prüfen

P1186 TREATMENT-NAIVE STABLE LIVER TRANSPLANT PATIENTS WITH GENOTYPE-1 HCV INFECTION: PHARMACOKINETIC RESULTS OF ADJUSTED DOSING WITH TACROLIMUS OR CYCLOSPORINE IN THE TELAPREVIR REPLACE STUDY

Journal of hepatology, 2014-04, Vol.60 (1), p.S481-S482

2014

Link zum Volltext

Verfügbarkeit prüfen

O004 : On-treatment virologic response and tolerability of simeprevir, daclatasvir and ribavirin in patients with recurrent hepatitis c virus genotype 1b infection after orthotopic liver transplantation (OLT): Interim data from the phase II saturn study

Journal of hepatology, 2015-04, Vol.62, p.S191-S192

2015

Link zum Volltext

Verfügbarkeit prüfen

P0772 : Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of HCV in patients with severe liver disease: Interim results of a multicenter compassionate use program

Journal of hepatology, 2015-04, Vol.62, p.S619-S620

2015

Link zum Volltext

Verfügbarkeit prüfen

P1185 INTERIM SVR12 RESULTS FROM THE TELAPREVIR PHASE 3B REPLACE STUDY IN TREATMENT-NAIVE STABLE LIVER TRANSPLANT PATIENTS WITH GENOTYPE 1 HCV INFECTION

Journal of hepatology, 2014-04, Vol.60 (1), p.S481-S481

2014

Link zum Volltext

Verfügbarkeit prüfen

Expert recommendations: Hepatitis C and transplantation

Zeitschrift fur Gastroenterologie, 2016-07, Vol.54 (7), p.665

2016

Link zum Volltext

Verfügbarkeit prüfen

Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis

BMJ (Online), 2011-08, Vol.343 (7822), p.d5094

International edition, 2011

Link zum Volltext

Verfügbarkeit prüfen

Die Interaktion zwischen Leber und Herz

Zeitschrift für Herz-, Thorax- und Gefässchirurgie, 2010-12, Vol.24 (6), p.334-340

2010

Link zum Volltext

Verfügbarkeit prüfen

HCV reinfection after liver transplantation - management and first experiences with telaprevir-based triple therapy

Deutsche medizinische Wochenschrift (1946), 2013-09, Vol.138 (36), p.1759

2013

Link zum Volltext

Verfügbarkeit prüfen

958 EXTRAHEPATIC MALIGNANCIES AFTER LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS – A LONG-TERM FOLLOW-UP OBSERVATIONAL STUDY OF A LARGE, MULTICENTER COHORT

Journal of hepatology, 2013-04, Vol.58, p.S395-S395

2013

Link zum Volltext

Verfügbarkeit prüfen

Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy

Cancer letters, 2006-10, Vol.242 (1), p.104-111

2006

Link zum Volltext

Verfügbarkeit prüfen

97 BILIARY STRICTURES AND RECURRENT DISEASE AFTER LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS – A LARGE, MULTICENTER COHORT ANALYSIS WITH LONG-TERM FOLLOW-UP

Journal of hepatology, 2013-04, Vol.58, p.S42-S43

2013

Link zum Volltext

Verfügbarkeit prüfen

THU-027 - CCNT1 mediates mTor inhibitor related antiviral effects in HCV genotype 2a

Journal of hepatology, 2018-04, Vol.68, p.S136-S136

2018

Link zum Volltext

Verfügbarkeit prüfen

CCNT1 mediates mTor inhibitor related antiviral effects in HCV genotype 2a

Journal of hepatology, 2018-04, Vol.68, p.S136

2018

Link zum Volltext

Verfügbarkeit prüfen

FRI-396 - Treatment of HCV infection with DAAs is associated with lower HCC recurrence and improved survival after liver transplant

Journal of hepatology, 2018-04, Vol.68, p.S540-S540

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment of HCV infection with DAAs is associated with lower HCC recurrence and improved survival after liver transplant

Journal of hepatology, 2018-04, Vol.68, p.S540

2018

Link zum Volltext

Verfügbarkeit prüfen

Donor specific antibodies after liver transplantation-still an underestimated risk?

Journal of hepatology, 2018-04, Vol.68, p.S26

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 253

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(193)

Publikationsform

Sprache

Englisch
(182)
Deutsch
(71)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Liver transplantation--an update

Donor Specific Antibodies Post Liver Transplant: Predictors and Protectors

Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo

Hepatitis viruses: live and let die

P0693 : The tumor suppressor PML mediates everolimus- induced changes of the HCV replication activity

Daclatasvir plus Sofosbuvir with or without Ribavirin for Treatment of Chronic HCV Infection in Patients with Advanced Liver Disease: Results of a European Compassionate use Program

Daclatasvir plus Sofosbuvir with or without Ribavirin for the Treatment of Chronic HCV Infection in Patients with Decompensated Cirrhosis: Results of a European Multicentre Compassionate Use Program

How do anaesthetists in New Zealand disseminate critical airway information?

P1186 TREATMENT-NAIVE STABLE LIVER TRANSPLANT PATIENTS WITH GENOTYPE-1 HCV INFECTION: PHARMACOKINETIC RESULTS OF ADJUSTED DOSING WITH TACROLIMUS OR CYCLOSPORINE IN THE TELAPREVIR REPLACE STUDY

O004 : On-treatment virologic response and tolerability of simeprevir, daclatasvir and ribavirin in patients with recurrent hepatitis c virus genotype 1b infection after orthotopic liver transplantation (OLT): Interim data from the phase II saturn study

P0772 : Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of HCV in patients with severe liver disease: Interim results of a multicenter compassionate use program

P1185 INTERIM SVR12 RESULTS FROM THE TELAPREVIR PHASE 3B REPLACE STUDY IN TREATMENT-NAIVE STABLE LIVER TRANSPLANT PATIENTS WITH GENOTYPE 1 HCV INFECTION

Expert recommendations: Hepatitis C and transplantation

Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis

Die Interaktion zwischen Leber und Herz

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort

HCV reinfection after liver transplantation - management and first experiences with telaprevir-based triple therapy

958 EXTRAHEPATIC MALIGNANCIES AFTER LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS – A LONG-TERM FOLLOW-UP OBSERVATIONAL STUDY OF A LARGE, MULTICENTER COHORT

Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapy

97 BILIARY STRICTURES AND RECURRENT DISEASE AFTER LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS – A LARGE, MULTICENTER COHORT ANALYSIS WITH LONG-TERM FOLLOW-UP

THU-027 - CCNT1 mediates mTor inhibitor related antiviral effects in HCV genotype 2a

CCNT1 mediates mTor inhibitor related antiviral effects in HCV genotype 2a

FRI-396 - Treatment of HCV infection with DAAs is associated with lower HCC recurrence and improved survival after liver transplant

Treatment of HCV infection with DAAs is associated with lower HCC recurrence and improved survival after liver transplant

Donor specific antibodies after liver transplantation-still an underestimated risk?

Suchergebnisse filtern